Brief: Viva Biotech Posts FY Adjusted Non-IFRS Net Profit Of RMB352.5 Million
28/03/2022 16:22
March 28 (Reuters) - VIVA Biotech Holdings 1873.HK :
* FY ADJUSTED NON-IFRS NET PROFIT RMB352.5 MILLION VERSUS
RMB252.3
MILLION
* FY REVENUE RMB2,104.1 MILLION VERSUS RMB697.0 MILLION
Source text for Eikon: ID:nHKS2ML41y
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical